Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 2/2016

01.06.2016 | Original Article

Evaluation of ETV6/RUNX1 Fusion and Additional Abnormalities Involving ETV6 and/or RUNX1 Genes Using FISH Technique in Patients with Childhood Acute Lymphoblastic Leukemia

verfasst von: Cigdem Aydin, Zafer Cetin, Ayse Esra Manguoglu, Funda Tayfun, Ozden Altiok Clark, Alphan Kupesiz, Bahar Akkaya, Sibel Berker Karauzum

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Childhood acute lymphoblastic leukemia (ALL) is the most common type of childhood leukemia. Specifically, ALL is a malignant disorder of the lymphoid progenitor cells, with a peak incidence among children aged 2–5 years. The t(12;21)(p13;q22) translocation occurs in 25 % of childhood B cell precursor ALL. In this study, bone marrow samples were obtained from 165 patients with childhood ALL. We analyzed the t(12;21) translocation and other related abnormalities using the fluorescent in situ hybridization (FISH) technique with the ETV6(TEL)/RUNX1(AML1) ES dual color translocation probe. Conventional cytogenetic analyses were also performed. ETV6 and RUNX1 related chromosomal abnormalities were found in 42 (25.5 %) of the 165 patients with childhood ALL. Among these 42 patients, structural changes were detected in 33 (78.6 %) and numerical abnormalities in 9 (21.4 %). The frequency of FISH abnormalities in pediatric ALL cases were as follows: 8.5 % for t(12;21)(p13;q22) ETV6/RUNX1 fusion, 6.0 % for RUNX1 amplification, 3.0 % for tetrasomy/trisomy 21, 1.8 % for ETV6 deletion, 1.21 % for ETV6 deletion with RUNX1 amplification, 1.21 % for ETV6 amplification with RUNX1 amplification, 0.6 % for polyploidy, 0.6 % for RUNX1 deletion, and 0.6 % for diminished ETV6 signal. The most common structural abnormality was the t(12;21) translocation, followed by RUNX1 amplification and ETV6 deletion, while the most commonly observed numerical abnormality was trisomy 21.
Literatur
1.
Zurück zum Zitat Kebriaei P, Anastasi J, Larson RA (2002) Acute lymphoblastic leukaemia: diagnosis and classification. Best Pract Res Clin Haematol 15(4):597–621CrossRefPubMed Kebriaei P, Anastasi J, Larson RA (2002) Acute lymphoblastic leukaemia: diagnosis and classification. Best Pract Res Clin Haematol 15(4):597–621CrossRefPubMed
2.
Zurück zum Zitat Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer Statistics, 2000. CA Cancer J Clin 50:7–33CrossRefPubMed Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer Statistics, 2000. CA Cancer J Clin 50:7–33CrossRefPubMed
3.
Zurück zum Zitat McNally RJ, Rowland D, Roman E, Cartwright RA (1997) Age and Sex distribution of Hematological Malignancies in the UK. Hematol Oncol 15:173–189CrossRefPubMed McNally RJ, Rowland D, Roman E, Cartwright RA (1997) Age and Sex distribution of Hematological Malignancies in the UK. Hematol Oncol 15:173–189CrossRefPubMed
4.
Zurück zum Zitat Ma SK, Wan TS, Chan LC (1999) Cytogenetics and molecular genetics of childhood leukemia. Hematol Oncol 17:91–105CrossRefPubMed Ma SK, Wan TS, Chan LC (1999) Cytogenetics and molecular genetics of childhood leukemia. Hematol Oncol 17:91–105CrossRefPubMed
5.
Zurück zum Zitat Woo HY, Kim DW, Park H, Seong KW, Koo HH, Kim SH (2005) Molecular Cytogenetic Analysis of Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia. J Korean Med Sci 20(1):36–41CrossRefPubMedPubMedCentral Woo HY, Kim DW, Park H, Seong KW, Koo HH, Kim SH (2005) Molecular Cytogenetic Analysis of Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia. J Korean Med Sci 20(1):36–41CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Romana SP, Le Coniat M, Berger R (1994) t(12;21):a new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosom Cancer 9:186–191CrossRefPubMed Romana SP, Le Coniat M, Berger R (1994) t(12;21):a new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosom Cancer 9:186–191CrossRefPubMed
7.
Zurück zum Zitat Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA (1995) The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85:3662–3670PubMed Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA (1995) The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85:3662–3670PubMed
8.
Zurück zum Zitat Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC-F, Pui C-H, Grosveld G (1995) TEL-AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985–1989PubMed Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC-F, Pui C-H, Grosveld G (1995) TEL-AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985–1989PubMed
9.
Zurück zum Zitat Harrison CJ (2001) The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukemia. Blood Rev 15:49–59CrossRefPubMed Harrison CJ (2001) The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukemia. Blood Rev 15:49–59CrossRefPubMed
10.
Zurück zum Zitat O’Connor HE, Butler TA, Clark R et al (1998) Abnormalities of the ETV6 gene occur in the majority of patients with aberrations of the short arm of chromosome 12: a combined PCR and Southern blotting analysis. Leukemia 12(7):1099–1106CrossRefPubMed O’Connor HE, Butler TA, Clark R et al (1998) Abnormalities of the ETV6 gene occur in the majority of patients with aberrations of the short arm of chromosome 12: a combined PCR and Southern blotting analysis. Leukemia 12(7):1099–1106CrossRefPubMed
11.
Zurück zum Zitat Raynaud S, Cave H, Baens M, Bastard C, Cacheux V, Grosgeorge J et al (1996) The 12; 21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87:2891–2899PubMed Raynaud S, Cave H, Baens M, Bastard C, Cacheux V, Grosgeorge J et al (1996) The 12; 21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87:2891–2899PubMed
12.
Zurück zum Zitat Romana SP, Le Coniat M, Poirel H, Marynen P, Bernard O, Berger R (1996) Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia 10:167–170PubMed Romana SP, Le Coniat M, Poirel H, Marynen P, Bernard O, Berger R (1996) Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia 10:167–170PubMed
13.
Zurück zum Zitat Kobayashi H, Satake N, Kaneko Y (1997) Detection of the Der(21)t(12; 21) chromosome forming the TEL-AML1 fusion gene in childhood acute lymphoblastic leukemia. Leukemia Lymphoma 28:43–50CrossRefPubMed Kobayashi H, Satake N, Kaneko Y (1997) Detection of the Der(21)t(12; 21) chromosome forming the TEL-AML1 fusion gene in childhood acute lymphoblastic leukemia. Leukemia Lymphoma 28:43–50CrossRefPubMed
14.
Zurück zum Zitat Loncarevic IF, Roitzheim B, Ritterbach J, Viehmann S, Borkhardt A, Lampert F et al (1999) Trisomy 21 is a recurrent secondary aberration in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion. Genes Chromosom Cancer 24:272–277CrossRefPubMed Loncarevic IF, Roitzheim B, Ritterbach J, Viehmann S, Borkhardt A, Lampert F et al (1999) Trisomy 21 is a recurrent secondary aberration in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion. Genes Chromosom Cancer 24:272–277CrossRefPubMed
15.
Zurück zum Zitat Kempski H, Chalker J, Chessells J, Sturt N, Brickell P, Webb J et al (1999) An investigation of the t(12;21) rearrangement in children with B precursor acute lymphoblastic leukaemia using cytogenetic and molecular methods. Br J Haematol 105:684–689CrossRefPubMed Kempski H, Chalker J, Chessells J, Sturt N, Brickell P, Webb J et al (1999) An investigation of the t(12;21) rearrangement in children with B precursor acute lymphoblastic leukaemia using cytogenetic and molecular methods. Br J Haematol 105:684–689CrossRefPubMed
16.
Zurück zum Zitat Van Dongen JJ, Macintyre EA, Gabert JA et al (1999) Standardized RT-PCR analysis of fusion gene transcript from chromosome aberrations in acute leukemia for detection of minimal residual disease. Leukemia 13:1901–1928CrossRefPubMed Van Dongen JJ, Macintyre EA, Gabert JA et al (1999) Standardized RT-PCR analysis of fusion gene transcript from chromosome aberrations in acute leukemia for detection of minimal residual disease. Leukemia 13:1901–1928CrossRefPubMed
17.
Zurück zum Zitat Inamdar N, Kumar SA, Banavali SD, Advani S, Magrath I, Bhatia K (1998) Comparative incidence of the rearrangements of TEL/AML1 and ALL1 genes in pediatric precursor B acute lymphoblastic leukemias in India. Int J Oncol 13:1319–1322PubMed Inamdar N, Kumar SA, Banavali SD, Advani S, Magrath I, Bhatia K (1998) Comparative incidence of the rearrangements of TEL/AML1 and ALL1 genes in pediatric precursor B acute lymphoblastic leukemias in India. Int J Oncol 13:1319–1322PubMed
18.
Zurück zum Zitat Forestier E, Andersen MK, Autio K et al (2007) Cytogenetic patterns in ETV6/RUNX1- positive pediatric B-cell precursor acute lymphoblastic leukemia: a Nordic series of 245 cases and review of the literature. Genes Chromosom Cancer 46:440–450CrossRefPubMed Forestier E, Andersen MK, Autio K et al (2007) Cytogenetic patterns in ETV6/RUNX1- positive pediatric B-cell precursor acute lymphoblastic leukemia: a Nordic series of 245 cases and review of the literature. Genes Chromosom Cancer 46:440–450CrossRefPubMed
19.
Zurück zum Zitat Liang DC, Chou TB, Chen JS, Shurtleff SA, Rubnitz JE, Downing JR et al (1996) High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia 10:991–993PubMed Liang DC, Chou TB, Chen JS, Shurtleff SA, Rubnitz JE, Downing JR et al (1996) High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia 10:991–993PubMed
20.
Zurück zum Zitat Tsang KS, Li CK, Chik KW, Shing MM, Tsoi WC, Ng MH et al (2001) TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong. Am J Hematol 68:91–98CrossRefPubMed Tsang KS, Li CK, Chik KW, Shing MM, Tsoi WC, Ng MH et al (2001) TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong. Am J Hematol 68:91–98CrossRefPubMed
21.
Zurück zum Zitat Veiga LBA, Coser VM, Cavalli LR et al (2004) High frequency of t(12;21)(p13;q22) in children with acute lymphoblastic leukaemia and known clinical outcome in southern Brazil. Leuk Res 28:1033–1038CrossRefPubMed Veiga LBA, Coser VM, Cavalli LR et al (2004) High frequency of t(12;21)(p13;q22) in children with acute lymphoblastic leukaemia and known clinical outcome in southern Brazil. Leuk Res 28:1033–1038CrossRefPubMed
22.
Zurück zum Zitat Harrison CJ, Moorman AV, Barber KE et al (2005) Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study. Br J Haematol 129:520–530CrossRefPubMed Harrison CJ, Moorman AV, Barber KE et al (2005) Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study. Br J Haematol 129:520–530CrossRefPubMed
23.
Zurück zum Zitat Borkhardt A, Cazzaniga G, Viehmann S et al (1997) Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukaemia enrolled in the German and Italian multicenter therapy trials. Blood 90:571–572PubMed Borkhardt A, Cazzaniga G, Viehmann S et al (1997) Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukaemia enrolled in the German and Italian multicenter therapy trials. Blood 90:571–572PubMed
24.
Zurück zum Zitat Chung HY, Kim KH, Jun KR, Jang S, Park CJ, Chi HS, Im HJ, Seo JJ, Seo EJ (2010) Prognostic significance of TEL/AML1 rearrangement and its additional genetic changes in korean childhood precursor b-acute lymphoblastic leukemia. Korean J Lab Med 30:1–8CrossRefPubMed Chung HY, Kim KH, Jun KR, Jang S, Park CJ, Chi HS, Im HJ, Seo JJ, Seo EJ (2010) Prognostic significance of TEL/AML1 rearrangement and its additional genetic changes in korean childhood precursor b-acute lymphoblastic leukemia. Korean J Lab Med 30:1–8CrossRefPubMed
25.
Zurück zum Zitat Ko DH, Jeon Y, Kang HJ, Park KD, Shin HY, Kim HK, Cho HI, Ahn HS, Lee DS (2011) Native ETV6 deletions accompanied by ETV6-RUNX1 rearrangements are associated with a favourable prognosis in childhood acute lymphoblastic leukaemia: a candidate for prognostic marker. Br J Haematol 155(4):530–533CrossRefPubMed Ko DH, Jeon Y, Kang HJ, Park KD, Shin HY, Kim HK, Cho HI, Ahn HS, Lee DS (2011) Native ETV6 deletions accompanied by ETV6-RUNX1 rearrangements are associated with a favourable prognosis in childhood acute lymphoblastic leukaemia: a candidate for prognostic marker. Br J Haematol 155(4):530–533CrossRefPubMed
26.
Zurück zum Zitat Attarbaschi A, Mann G, Konig M, Dworzak MN, Trebo MM, Muhlegger N, Gadner H, Haas OA (2004) Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1 + acute lymphoblastic leukemia: an interphase FISH analysis. Leukemia 18:1611–1616CrossRefPubMed Attarbaschi A, Mann G, Konig M, Dworzak MN, Trebo MM, Muhlegger N, Gadner H, Haas OA (2004) Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1 + acute lymphoblastic leukemia: an interphase FISH analysis. Leukemia 18:1611–1616CrossRefPubMed
27.
Zurück zum Zitat Park KU, She CJ, Shin HY, Ahn HS, Kim CJ, Cho BK, Cho HI, Lee DS (2001) The low incidences of TEL/AML1 fusion and TEL deletion in korean childhood acute leukemia by extra-signal fluorescence in situ hybridization. Cancer Genet Cytogenet 126:73–77CrossRefPubMed Park KU, She CJ, Shin HY, Ahn HS, Kim CJ, Cho BK, Cho HI, Lee DS (2001) The low incidences of TEL/AML1 fusion and TEL deletion in korean childhood acute leukemia by extra-signal fluorescence in situ hybridization. Cancer Genet Cytogenet 126:73–77CrossRefPubMed
28.
Zurück zum Zitat Lee DS, Kim YR, Cho HK, Lee CK, Lee JH, Cho HI (2005) The presence of TEL/AML1 rearrangement and cryptic deletion of the TEL gene in adult acute lymphoblastic leukemia (ALL). Cancer Genet Cytogenet 162:176–178CrossRefPubMed Lee DS, Kim YR, Cho HK, Lee CK, Lee JH, Cho HI (2005) The presence of TEL/AML1 rearrangement and cryptic deletion of the TEL gene in adult acute lymphoblastic leukemia (ALL). Cancer Genet Cytogenet 162:176–178CrossRefPubMed
29.
Zurück zum Zitat Gmidene A, Senana H, Elghezal H et al (2008) Cytogenetic analysis of 298 newly diagnosed cases of acute lymphoblastic leukemia in Tunisia. Hematol Oncol 26(2):91–97CrossRefPubMed Gmidene A, Senana H, Elghezal H et al (2008) Cytogenetic analysis of 298 newly diagnosed cases of acute lymphoblastic leukemia in Tunisia. Hematol Oncol 26(2):91–97CrossRefPubMed
30.
Zurück zum Zitat Izraeli S, Vora A, Zwaan CM, Whitlock J (2014) How I treat ALL in Down’s syndrome: pathobiology and management. Blood 123(1):35–40CrossRefPubMed Izraeli S, Vora A, Zwaan CM, Whitlock J (2014) How I treat ALL in Down’s syndrome: pathobiology and management. Blood 123(1):35–40CrossRefPubMed
Metadaten
Titel
Evaluation of ETV6/RUNX1 Fusion and Additional Abnormalities Involving ETV6 and/or RUNX1 Genes Using FISH Technique in Patients with Childhood Acute Lymphoblastic Leukemia
verfasst von
Cigdem Aydin
Zafer Cetin
Ayse Esra Manguoglu
Funda Tayfun
Ozden Altiok Clark
Alphan Kupesiz
Bahar Akkaya
Sibel Berker Karauzum
Publikationsdatum
01.06.2016
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 2/2016
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0557-7

Weitere Artikel der Ausgabe 2/2016

Indian Journal of Hematology and Blood Transfusion 2/2016 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.